A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib

Overview of attention for article published in Lung Cancer: Targets and Therapy, November 2022

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 10 Mendeley

Summary Reddit Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies

Article in Frontiers in Medicine (March 2024)

First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation

Article in Current Medicinal Chemistry (January 2024)

The current landscape of using direct inhibitors to target KRASG12C-mutated NSCLC

Article in Experimental Hematology & Oncology (November 2023)